A new study shows that rosacea patients pay more than "matched
controls.'

Here is what the study concludes:

"CONCLUSIONS: This is the first extensive study of rosacea and its
impact on healthcare utilization and costs in an insured population.
Although rosacea is a common illness that does not have much
financial impact on its sufferers, rosacea patients incurred slightly
higher direct total healthcare costs than matched controls."

For more info:

http://tinyurl.com/3c7jhh

Brady
group owner